Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 22298331)

Published in J Cell Biochem on June 01, 2012

Authors

Sebastiano Gangemi1, Paola Minciullo, Barbara Adamo, Tindara Franchina, Giuseppina R R Ricciardi, Maria Ferraro, Roberta Briguglio, Giuseppe Toscano, Salvatore Saitta, Vincenzo Adamo

Author Affiliations

1: School and Division of Allergy and Clinical Immunology, Department of Human Pathology, University Policlinic G. Martino, Messina, Italy.

Articles by these authors

Molecular characterization of basal-like and non-basal-like triple-negative breast cancer. Oncologist (2013) 2.55

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol (2005) 2.11

Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma. J Allergy Clin Immunol (2004) 1.59

Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: updated results and long-term survival. Gynecol Oncol (2005) 1.52

Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma. Cancer Treat Rev (2010) 1.45

Hepatic steatosis, carotid atherosclerosis and metabolic syndrome: the STEATO Study. J Gastroenterol (2009) 1.39

Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide-mediated responses in airway epithelial cells. Immunology (2008) 1.38

Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes. Breast Cancer Res Treat (2013) 1.27

A rare case of malignant solitary fibrous tumor of the spinal cord. Spine (Phila Pa 1976) (2008) 1.18

Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism. Eur J Pharmacol (2008) 1.13

Chronic obstructive pulmonary disease and neutrophil infiltration: role of cigarette smoke and cyclooxygenase products. Am J Physiol Lung Cell Mol Physiol (2009) 1.11

Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. J Clin Endocrinol Metab (2008) 1.10

Supportive care in patients with advanced non-small-cell lung cancer. Br J Cancer (2003) 1.04

Soil-catalyzed polymerization of phenolics in polluted waters. Water Res (2002) 1.03

The APOE epsilon4 allele increases the risk of impaired spatial working memory in obstructive sleep apnea. Sleep Med (2008) 1.03

Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer. J Cell Physiol (2014) 1.02

αB-crystallin: a novel regulator of breast cancer metastasis to the brain. Clin Cancer Res (2013) 1.02

Recommendations for mutational analysis of EGFR in lung carcinoma. Pathologica (2010) 1.00

Prospective multicenter study of combined treatment with chemotherapy and radiotherapy in breast cancer women with the rare clinical scenario of ipsilateral supraclavicular node recurrence without distant metastases. Int J Radiat Oncol Biol Phys (2006) 1.00

Natural History of Non-Small-Cell Lung Cancer with Bone Metastases. Sci Rep (2015) 0.99

Hepatotoxicity induced by methimazole in a previously healthy patient. Curr Drug Saf (2009) 0.99

State-of-the-art and emerging treatment options in the management of head and neck cancer: news from 2013. Oncology (2014) 0.97

Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis. Anticancer Res (2009) 0.96

TLR4 upregulation underpins airway neutrophilia in smokers with chronic obstructive pulmonary disease and acute respiratory failure. Hum Immunol (2010) 0.95

Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome. Clin Cancer Res (2008) 0.93

Peritoneal carcinomatosis of colorectal origin. World J Gastrointest Oncol (2010) 0.92

Cigarette smoke extract activates human bronchial epithelial cells affecting non-neuronal cholinergic system signalling in vitro. Life Sci (2011) 0.91

NSCLC and HER2: between lights and shadows. J Thorac Oncol (2014) 0.91

The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression. Eur Neuropsychopharmacol (2011) 0.90

Long-term durability of the Hancock II porcine bioprosthesis. J Thorac Cardiovasc Surg (2003) 0.90

Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer. PLoS One (2013) 0.89

Botox(®) for idiopathic overactive bladder: efficacy, duration and safety. Effectiveness of subsequent injection. Arch Gynecol Obstet (2012) 0.89

Increased serum levels of IL-22 in patients with nickel contact dermatitis. Contact Dermatitis (2009) 0.88

Beta defensin-2 is reduced in central but not in distal airways of smoker COPD patients. PLoS One (2012) 0.88

Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients? Transplantation (2010) 0.88

Role of prostaglandin E2 in the invasiveness, growth and protection of cancer cells in malignant pleuritis. Eur J Cancer (2006) 0.88

Smoke, choline acetyltransferase, muscarinic receptors, and fibroblast proliferation in chronic obstructive pulmonary disease. J Pharmacol Exp Ther (2009) 0.87

Triple-negative breast cancer: an update on neoadjuvant clinical trials. Int J Breast Cancer (2012) 0.86

Clinical benefits of 7 years of treatment with omalizumab in severe uncontrolled asthmatics. J Asthma (2011) 0.86

Coronary flow velocity pattern and coronary flow reserve by contrast-enhanced transthoracic echocardiography predict long-term outcome in heart transplantation. Circulation (2006) 0.86

Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis. Cancer (2009) 0.85

A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck. Anticancer Drugs (2008) 0.85

Stratifying triple-negative breast cancer: which definition(s) to use? Breast Cancer Res (2011) 0.85

Nonlocal effects: relevance for the spontaneous emission rates of quantum emitters coupled to plasmonic structures. Opt Lett (2014) 0.84

Occupational asthma due to exposure to iroko wood dust. Ann Allergy Asthma Immunol (2003) 0.84

Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection. J Clin Microbiol (2012) 0.84

Genotoxic effects of produced waters in mosquito fish (Gambusia affinis). Ecotoxicology (2008) 0.84

Apigenin affects leptin/leptin receptor pathway and induces cell apoptosis in lung adenocarcinoma cell line. Eur J Cancer (2011) 0.84

Gefitinib in lung cancer therapy: clinical results, predictive markers of response and future perspectives. Cancer Biol Ther (2009) 0.83

A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman. Curr Drug Saf (2009) 0.83

Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome. BMC Cancer (2008) 0.83

Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection. J Heart Lung Transplant (2013) 0.83

Interstitial pregnancy: a 'road map' of surgical treatment based on a systematic review of the literature. Gynecol Obstet Invest (2014) 0.83

β₂ long-acting and anticholinergic drugs control TGF-β1-mediated neutrophilic inflammation in COPD. Biochim Biophys Acta (2012) 0.82

Cysteinyl leukotriene-1 receptor activation in a human bronchial epithelial cell line leads to signal transducer and activator of transcription 1-mediated eosinophil adhesion. J Pharmacol Exp Ther (2008) 0.82

Bortezomib: a new pro-apoptotic agent in cancer treatment. Curr Cancer Drug Targets (2010) 0.82

In vitro anticholinergic drugs affect CD8+ peripheral blood T-cells apoptosis in COPD. Immunobiology (2011) 0.82

Outcome after pediatric heart transplantation: two decades of a single center experience. Eur J Cardiothorac Surg (2007) 0.82

Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study. Lung Cancer (2011) 0.82

The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population. Oncology (2013) 0.82

Insertional mutagenesis and development of malignancies induced by integrating gene delivery systems: implications for the design of safer gene-based interventions in patients. Drug News Perspect (2009) 0.81

Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study. Radiat Oncol (2011) 0.81

Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing. Immunology (2014) 0.81

Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 0.81

Pleural mesothelial cells express both BLT2 and PPARalpha and mount an integrated response to pleural leukotriene B4. J Immunol (2008) 0.81

Emerging targeted therapies for castration-resistant prostate cancer. Front Endocrinol (Lausanne) (2012) 0.81

Serum interleukin-23 (IL-23) is increased in Hashimoto's thyroiditis. Endocr J (2014) 0.80

Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease. Br J Haematol (2012) 0.80

Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: two case reports. Cancer Biol Ther (2012) 0.80

Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions. Eur J Cancer (2011) 0.80

Decreased plasma levels of IL-33 could contribute to the altered function of Th2 lymphocytes in patients with polycythemia vera and essential thrombocythemia. Cancer Invest (2013) 0.80

Cilomilast counteracts the effects of cigarette smoke in airway epithelial cells. Cell Immunol (2011) 0.80

Serum levels of protein oxidation products in patients with nickel allergy. Allergy Asthma Proc (2009) 0.80

Healthy centenarians show high levels of circulating interleukin-22 (IL-22). Arch Gerontol Geriatr (2011) 0.80

Carbocysteine regulates innate immune responses and senescence processes in cigarette smoke stimulated bronchial epithelial cells. Toxicol Lett (2013) 0.79

Oxidative stress markers in patients with hymenoptera venom allergy. Allergy Asthma Proc (2015) 0.79

Oseltamivir-resistant pandemic (H1N1) 2009 treated with nebulized zanamivir. Emerg Infect Dis (2010) 0.79

ABO-incompatible heart transplantation: crossing the immunological barrier. J Cardiovasc Med (Hagerstown) (2008) 0.79

Elevated expression of prostaglandin receptor and increased release of prostaglandin E2 maintain the survival of CD45RO+ T cells in the inflamed human pleural space. Immunology (2007) 0.78

Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients. Oncol Rep (2011) 0.78

The role of p21 Waf1/Cip1 in large airway epithelium in smokers with and without COPD. Biochim Biophys Acta (2013) 0.78

Comparative cytoprotective effects of carbocysteine and fluticasone propionate in cigarette smoke extract-stimulated bronchial epithelial cells. Cell Stress Chaperones (2013) 0.78

Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients. Acta Oncol (2011) 0.78

Reduction in IL-33 plasma levels might be involved in T cell dysregulation in chronic lymphocytic leukemia. Acta Haematol (2013) 0.78

Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors. Menopause (2017) 0.77

Increased serum levels of advanced oxidation protein products and glycation end products in subjects exposed to low-dose benzene. Int J Hyg Environ Health (2011) 0.77

Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia. Cell Immunol (2012) 0.77

Correction: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients. PLoS One (2015) 0.77